financetom
Business
financetom
/
Business
/
Sabre to cut debt with $1.1-billion sale of hospitality software to TPG, shares jump
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sabre to cut debt with $1.1-billion sale of hospitality software to TPG, shares jump
May 25, 2025 8:06 PM

(Reuters) -Sabre Corp said on Monday it will sell its hospitality software platform to asset manager TPG for $1.1 billion and use the cash to pare its debt, lifting the travel technology provider's shares nearly 26% in early trading.

The company had a market capitalization of $845 million as of last close, according to LSEG data. In contrast, its total debt stood at about $4.5 billion, net of cash, as of December-end, according to its annual filing.

Sabre has made several moves to pare its debt, including refinancing in December and the repayment of debt maturities earlier this month, the company said.

Monday's deal comes a month after Reuters reported that Sabre was exploring a sale of its hospitality software SynXis to help pare its debt.

TPG will invest in the unit through its U.S. and European private equity platform, with the transaction expected to close by the end of the third quarter 2025.

Sabre's SynXis serves as an integrated system of record for reservation and guest information.

The deal also comes at a time of uncertainty for the travel industry due to fears of an economic recession stemming from U.S. President Donald Trump's sweeping import tariffs.

Many airlines, including legacy carriers Delta, Southwest

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
UroGen Pharma Says FDA Accepts Investigational New Drug Application for Potential Bladder Cancer Treatment
UroGen Pharma Says FDA Accepts Investigational New Drug Application for Potential Bladder Cancer Treatment
Apr 15, 2024
09:02 AM EDT, 04/15/2024 (MT Newswires) -- UroGen Pharma ( URGN ) said Monday that the US Food and Drug Administration has accepted its Investigational New Drug application for UGN-103, a potential treatment for low-grade intermediate-risk non-muscle invasive bladder cancer. UroGen said it plans to launch a phase 3 study this year to test the safety and effectiveness of its...
Charles Schwab's profit drops on higher interest payouts
Charles Schwab's profit drops on higher interest payouts
Apr 15, 2024
(Reuters) - Charles Schwab's ( SCHW ) first-quarter profit fell 15% as higher interest on clients' deposits and its borrowings offset gains from a surge in asset management fees, the brokerage said on Thursday. Rate hikes by the U.S. Federal Reserve have compelled companies like Schwab to increase the interest they pay on deposits - a crucial source of capital...
High Flood Scores Seen For Municipal Bond Offerings This Week
High Flood Scores Seen For Municipal Bond Offerings This Week
Apr 15, 2024
08:57 AM EDT, 04/15/2024 (MT Newswires) -- Multiple municipal bond offerings this week have a high exposure to climate risk, specifically high Flood Scores, according to ICE Climate Data. A $14 million offering from Duxbury, Mass., records a Flood Score of 4.9 out of 5.0, ICE reports. Locations with a component Physical Climate Risk Score, which includes Flood, Wildfire and...
Sector Update: Consumer
Sector Update: Consumer
Apr 15, 2024
08:53 AM EDT, 04/15/2024 (MT Newswires) -- Consumer stocks were edging higher premarket Monday as the Consumer Staples Select Sector SPDR Fund (XLP) was up 0.5% and the Consumer Discretionary Select Sector SPDR Fund (XLY) was advancing 0.6%. Bally's (BALY) was down 0.9% after filing a prospectus Friday for the sale of up to 7.9 million of its common shares...
Copyright 2023-2026 - www.financetom.com All Rights Reserved